Your browser doesn't support javascript.
loading
Longitudinal motor decline in dementia with Lewy bodies, Parkinson disease dementia, and Alzheimer's dementia in a community autopsy cohort.
Choudhury, Parichita; Zhang, Nan; Adler, Charles H; Chen, Kewei; Belden, Christine; Driver-Dunckley, Erika; Mehta, Shyamal H; Shprecher, David R; Serrano, Geidy E; Shill, Holly A; Beach, Thomas G; Atri, Alireza.
Afiliação
  • Choudhury P; Cleo Roberts Center, Banner Sun Health Research Institute, Sun City, Arizona, USA.
  • Zhang N; Department of Quantitative Health Sciences, Mayo Clinic College of Medicine, Scottsdale, Arizona, USA.
  • Adler CH; Department of Neurology, Mayo Clinic College of Medicine, Scottsdale, Arizona, USA.
  • Chen K; Computational Imaging Lab, Banner Alzheimer's Institute, Phoenix, Arizona, USA.
  • Belden C; Cleo Roberts Center, Banner Sun Health Research Institute, Sun City, Arizona, USA.
  • Driver-Dunckley E; Department of Neurology, Mayo Clinic College of Medicine, Scottsdale, Arizona, USA.
  • Mehta SH; Department of Neurology, Mayo Clinic College of Medicine, Scottsdale, Arizona, USA.
  • Shprecher DR; Cleo Roberts Center, Banner Sun Health Research Institute, Sun City, Arizona, USA.
  • Serrano GE; Civin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, Arizona, USA.
  • Shill HA; Department of Neurology, Barrow Neurological Institute, Phoenix, Arizona, USA.
  • Beach TG; Civin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, Arizona, USA.
  • Atri A; Cleo Roberts Center, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Alzheimers Dement ; 19(10): 4377-4387, 2023 10.
Article em En | MEDLINE | ID: mdl-37422286
ABSTRACT

INTRODUCTION:

We examined the progression of extrapyramidal symptoms and signs in autopsy-confirmed dementia with Lewy bodies (DLB), Parkinson's disease dementia (PDD), and Alzheimer's disease dementia (AD).

METHODS:

Longitudinal data were obtained from Arizona Study of Aging and Neurodegenerative Disease, with PDD (n = 98), AD (n = 47) and DLB (n = 48) further sub-grouped as with or without parkinsonism (DLB+ and DLB-). Within-group Unified Parkinson's Disease Rating Scale (UPDRS) -II and UPDRS-III trajectories were analyzed using non-linear mixed effects models.

RESULTS:

In DLB, 65.6% had parkinsonism. Baseline UPDRS-II and III scores (off-stage) were highest (P < 0.001) for PDD (mean ± SD 14.3 ± 7.8 and 27.4 ± 16.3), followed by DLB+ (6.0 ± 8.8 and 17.2 ± 17.1), DLB- (1.1 ± 1.3 and 3.3 ± 5.5) and AD (3.2 ± 6.1 and 8.2 ± 13.6). Compared to PDD, the DLB+ group had faster UPDRS-III progression over 8-years (Cohen's-d range 0.98 to 2.79, P < 0.001), driven by gait (P < 0.001) and limb bradykinesia (P = 0.02) subscales.

DISCUSSION:

Motor deficits progress faster in DLB+ than PDD, providing insights about expected changes in motor function. HIGHLIGHTS Dementia with Lewy bodies has faster motor progression than Parkinson's disease dementia Linear and non-linear mixed modeling analysis of longitudinal data was utilized Findings have implications for clinical prognostication and trial design.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Doenças Neurodegenerativas / Doença por Corpos de Lewy / Demência / Doença de Alzheimer Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Alzheimers Dement Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Doenças Neurodegenerativas / Doença por Corpos de Lewy / Demência / Doença de Alzheimer Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Alzheimers Dement Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos